<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Transient ischemic attack (TIA) and minor ischemic stroke: Rapid overview of emergency management</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Transient ischemic attack (TIA) and minor ischemic stroke: Rapid overview of emergency management</h1>
<div class="graphic"><div class="figure"><div class="ttl">Transient ischemic attack (TIA) and minor ischemic stroke: Rapid overview of emergency management</div><div class="cntnt"><table cellspacing="0"><tbody> <tr> <td class="subtitle1_single">Clinical features</td> </tr> <tr> <td class="indent1"> <ul> <li><strong>Typical TIAs</strong> are characterized by transient, focal neurologic symptoms that can be localized to a single vascular territory within the brain, including one or more of the following: <ul> <li>Transient monocular blindness (amaurosis fugax)</li> <li>Aphasia or dysarthria</li> <li>Hemianopia</li> <li>Hemiparesis and/or hemisensory loss (complete or partial)</li> </ul> </li> <li><strong>Atypical TIAs</strong> may present with transient isolated neurologic symptoms: <ul> <li>Isolated vertigo</li> <li>Isolated ataxia</li> <li>Isolated diplopia</li> <li>Isolated speech disturbance (slurred speech) without aphasia</li> <li>Isolated bilateral decreased vision</li> <li>Isolated unilateral sensory loss involving only one body part</li> </ul> </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Differential diagnosis</td> </tr> <tr> <td class="indent1"> <ul> <li>Seizure</li> <li>Migraine aura</li> <li>Syncope</li> <li>Transient global amnesia</li> <li>Central nervous system demyelinating disorder (eg, multiple sclerosis)</li> <li>Peripheral vestibulopathy</li> <li>Metabolic disorder (eg, hypoglycemia)</li> <li>Myasthenia gravis</li> <li>Cranial/peripheral neuropathy</li> <li>Cerebral amyloid angiopathy</li> <li>Subdural hematoma</li> <li>Subarachnoid or intracerebral hemorrhage</li> <li>Transient neurologic attack not otherwise specified</li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Immediate treatment while evaluating the ischemic mechanism</td> </tr> <tr> <td class="indent1"> <ul> <li>For patients with TIA or minor, nondisabling acute ischemic stroke (and thus not eligible for thrombolytic therapy or mechanical thrombectomy), start antiplatelet therapy immediately while the evaluation is in progress: <ul> <li>Start DAPT (aspirin plus clopidogrel, or aspirin plus ticagrelor) for patients with one of the following: <ul> <li>High-risk TIA, defined by an <span class="nowrap_whitespace">ABCD<sup>2</sup></span> score ≥4</li> <li>Time-based TIA with a relevant large artery stenosis or DWI lesion on MRI (if imaging available at this stage)</li> <li>Minor, nondisabling ischemic stroke, defined by an NIHSS score ≤5</li> </ul> </li> <li>Start aspirin monotherapy for patients who do not meet the above criteria (ie, TIA with an <span class="nowrap_whitespace">ABCD<sup>2</sup></span> score &lt;4 and no relevant large artery stenosis or DWI lesion on MRI [if imaging available at this stage])</li> </ul> </li> <li>Once the ischemic mechanism is determined, antithrombotic therapy can be modified as necessary</li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Urgent evaluation</td> </tr> <tr> <td class="indent1"> <ul> <li>Brain imaging with diffusion-weighted MRI (preferred) or CT to identify infarction and rule out nonischemic causes</li> <li>Vascular imaging of extracranial and intracranial large arteries with MRA or CTA to identify large artery cause</li> <li>Cardiac evaluation (ECG, cardiac monitoring, echocardiography) to identify atrial fibrillation or other cardioembolic source</li> <li>Laboratories: CBC, PT and PTT, serum electrolytes, creatinine, fasting blood glucose or HbA1c, lipids, and (as indicated for selected patients) ESR and CRP</li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Targeted treatment by mechanism for secondary prevention</td> </tr> <tr> <td class="indent1"> <ul> <li>Cardiogenic embolism due to atrial fibrillation: Stop antiplatelet agents and start long-term anticoagulation</li> <li>Symptomatic internal carotid artery stenosis: Carotid revascularization with CEA or CAS and long-term antiplatelet therapy</li> <li>Intracranial large artery atherosclerosis with 70 to 99% stenosis: Continue DAPT for 21 to 90 days, then switch to long-term single-agent antiplatelet therapy</li> <li>Small vessel disease, extracranial vertebral artery stenosis, intracranial large artery atherosclerosis with 50 to 69% stenosis, or cryptogenic: <ul> <li>Continue DAPT for 21 days, then switch to long-term single-agent antiplatelet therapy for: <ul> <li>High-risk TIA <span class="nowrap_whitespace">(ABCD<sup>2</sup></span> score ≥4), or TIA with a relevant DWI lesion on MRI, or extracranial stenosis not amenable to revascularization</li> <li>Minor ischemic stroke (NIHSS ≤5)</li> </ul> </li> <li>Continue long-term single-agent antiplatelet therapy for low-risk TIA <span class="nowrap_whitespace">(ABCD<sup>2</sup></span> score &lt;4), and TIA without a relevant large artery stenosis or DWI lesion on MRI</li> </ul> </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Intensive risk factor management</td> </tr> <tr> <td class="indent1"> <ul> <li>Antihypertensive therapy for patients with known or newly established hypertension</li> <li>LDL-cholesterol lowering with high-intensity statin therapy</li> <li>Glucose control to near normoglycemic levels for patients with diabetes</li> <li>Lifestyle modification as appropriate: <ul> <li>Moderate to vigorous exercise most days of the week for those capable</li> <li>Smoking cessation for recent or current tobacco users</li> <li>Mediterranean diet</li> <li>Weight reduction for patients with obesity</li> <li>Reduced alcohol consumption for heavy drinkers</li> </ul> </li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd">This rapid overview presents a general approach to the management of TIA and minor stroke. Please refer to UpToDate content for details, including descriptions and calculators for the NIHSS and <span class="nowrap_whitespace">ABCD<sup>2</sup></span> scores.</div><div class="graphic_footnotes">DAPT: dual antiplatelet therapy; <span class="nowrap_whitespace">ABCD<sup>2</sup>:</span> Age, Blood pressure, Clinical features, Duration of symptoms, and Diabetes; NIHSS: National Institutes of Health Stroke Scale; DWI: diffusion-weighted imaging; MRI: magnetic resonance imaging; CT: computed tomography; MRA: magnetic resonance angiography; CTA: computed tomographic angiography; ECG: electrocardiography; CBC: complete blood count; PT: prothrombin time; PTT: partial thromboplastin time; HbA1c: glycated hemoglobin; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; CEA: carotid endarterectomy; CAS: carotid artery stenting; LDL: low density lipoprotein; ICAS: intracranial larger artery atherosclerosis.</div><div id="graphicVersion">Graphic 131201 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
